Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile

Author(s):
Velden, D. van der; Lagraauw, H.M.; Wezel, A.; Launay, P.; Kuiper, J.; Huizinga, T.W.J. (0000-0001-7033-7520); Toes, R.E.M. (0000-0002-9618-6414); Bot, I.; Stoop, J.N.
Published
2016
Publication type
Article / Letter to editor
Mast cellsCollagen-induced arthritisRMB miceT cells
Date issued
2016-06-13
Language
English
Is part of
Arthritis Research and Therapy
hdl
1887/112252
doi
10.1186/s13075-016-1036-8